Cure My Disease

Don't miss your cure!

 Log in / Sign up

Group emotion regulation therapy put to the test for teen self-harm

NCT ID NCT07720063

Not yet recruiting Disease control Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a 12-week group therapy program called Emotion Regulation for Adolescents (ERA) can reduce non-suicidal self-injury in teens aged 13 to 17. Participants must have self-harmed at least five times in the past year, including once in the past month. The program teaches skills to manage difficult emotions and reduce impulsive behaviors, with a separate parent group. The study compares ERA to an active control condition to see if it works better than standard support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 12-week manualized group emotion regulation therapy (ERA) plus a parallel 5-session parent program
What this could lead to
If effective, ERA could provide a brief, scalable group treatment for adolescent self-harm within routine mental health services.
What could go wrong
This is a relatively early-stage trial with 180 participants; the active control condition may also reduce self-harm, making it hard to show a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SUICIDAL SELF INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SUICIDAL SELF INJURY NON-SUICIDAL SELF-INJURY (NSSI) SELF-HARM SELF-HARM BEHAVIOR SELF-HARM, DELIBERATE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.